Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying ...
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
Novo Nordisk should remain one of the leaders in the fast-growing weight loss market, and the company's shares are trading at ...
Nodule and lipoma formation can occur rarely after an intramuscular influenza vaccination, particularly when administered ...
SLIT vs SCIT: Which Immunotherapy Works Best for Children With Allergic Rhinitis? Review Sheds Light
A systematic review of randomized clinical trials suggests that both sublingual and subcutaneous allergen immunotherapy are effective options for managing allergic rhinitis ...
Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 22.1% year on year to $354.3 million.
Hemophilia A and B involve deficiencies in coagulation factors VIII and IX, with traditional treatments requiring frequent infusions. Nonfactor therapies, including Hemlibra and rebalancing agents, ...
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
To access our top 5 gated pieces of 2025, however, readers must first tell us a little bit about themselves.
Novo Nordisk's shares look reasonably valued. Thankfully, 2026 could be a much better year for the Denmark-based drugmaker.
TikTok star Anna Paul has hit back at online trolls after claims circulated that bruises on her body were linked to Ozempic use, firmly denying she has ever taken the weight-loss drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback